Display Settings:

Format

Send to:

Choose Destination
    Ann Oncol. 2004 Apr;15(4):550-8.

    Treatment for Waldenstrom's macroglobulinemia.

    Source

    Princess Margaret Hospital/Ontario Cancer Institute, Toronto, Ontario, Canada. Christine.chen@uhn.on.ca

    Abstract

    Waldenstrom's macroglobulinemia is a rare form of indolent lymphoma characterized by the production of a monoclonal immunoglobulin M protein, and complications such as hyperviscosity, cytopenias and peripheral neuropathy. Conventional treatment approaches are based on alkylators or nucleoside analogs, but in the absence of a clearly superior regimen, a broad array of alternative therapies exists. Choices range from biological agents to combination chemotherapy to stem-cell transplantation. A rational approach therefore must be based on careful patient assessment and individualization of therapy.

    PMID:
    15033658
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk